tiprankstipranks
Arovella Therapeutics Limited (AU:ALA)
ASX:ALA
Australian Market

Arovella Therapeutics Limited (ALA) Income Statement

Compare
11 Followers

Arovella Therapeutics Limited Income Statement

Last quarter (Q4 2024), Arovella Therapeutics Limited's total revenue was AU$4.25K, a decrease of -83.85% from the same quarter last year. In Q4, Arovella Therapeutics Limited's net income was AU$-2.40M. See Arovella Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 17.00KAU$ 405.90KAU$ 295.81KAU$ 257.35KAU$ 532.69K
Gross Profit
AU$ -25.98KAU$ -3.00MAU$ 88.75KAU$ 34.60KAU$ 331.72K
Operating Expenses
AU$ 10.79MAU$ 6.68MAU$ 7.69MAU$ 4.70MAU$ 5.14M
Depreciation and Amortization
AU$ 42.98KAU$ 837.18KAU$ 551.49KAU$ 652.18KAU$ 572.38K
EBITDA
AU$ -8.83MAU$ -10.37MAU$ -7.87MAU$ -4.99MAU$ -3.40M
Operating Income
AU$ -10.81MAU$ -9.68MAU$ -7.59MAU$ -3.75MAU$ -3.98M
Other Income/Expenses
AU$ 2.07MAU$ -1.55MAU$ -1.02MAU$ -1.29MAU$ -2.93M
Pretax Income
AU$ -8.75MAU$ -11.23MAU$ -8.62MAU$ -5.05MAU$ -9.94M
Net Income
AU$ -8.75MAU$ -10.18MAU$ -8.62MAU$ -5.05MAU$ -9.94M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.01AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.06
Diluted EPS
AU$ -0.01AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.06
Weighted Average Shares Outstanding
941.42M 711.48M 549.62M 330.89M 167.91M
Weighted Average Shares Outstanding (Diluted)
941.42M 711.48M 549.62M 330.89M 167.91M
Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis